BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 24355598)

  • 1. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS.
    Yamashita T; Kwak S
    Neurosci Res; 2019 Jul; 144():4-13. PubMed ID: 29944911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
    Kwak S
    Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calpain plays a crucial role in TDP-43 pathology].
    Yamashita T; Kwak S
    Rinsho Shinkeigaku; 2014; 54(12):1151-4. PubMed ID: 25672733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons.
    Yamashita T; Hideyama T; Teramoto S; Kwak S
    Neurosci Res; 2012 Jun; 73(2):153-60. PubMed ID: 22414730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy in spinal motor neurons of conditional ADAR2-knockout mice: An implication for a role of calcium in increased autophagy flux in ALS.
    Sasaki S; Yamashita T; Kwak S
    Neurosci Lett; 2015 Jun; 598():79-84. PubMed ID: 25980994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Intracellular Milieu of ADAR2-Deficient Motor Neurons in Amyotrophic Lateral Sclerosis.
    Yamashita T; Akamatsu M; Kwak S
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2.
    Aizawa H; Sawada J; Hideyama T; Yamashita T; Katayama T; Hasebe N; Kimura T; Yahara O; Kwak S
    Acta Neuropathol; 2010 Jul; 120(1):75-84. PubMed ID: 20372915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
    Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
    J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
    Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
    Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS(P525L) mutation.
    Aizawa H; Hideyama T; Yamashita T; Kimura T; Suzuki N; Aoki M; Kwak S
    J Clin Neurosci; 2016 Oct; 32():128-9. PubMed ID: 27343041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurrence of TDP-43 mislocalization with reduced activity of an RNA editing enzyme, ADAR2, in aged mouse motor neurons.
    Hideyama T; Teramoto S; Hachiga K; Yamashita T; Kwak S
    PLoS One; 2012; 7(8):e43469. PubMed ID: 22916266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique nuclear vacuoles in the motor neurons of conditional ADAR2-knockout mice.
    Sasaki S; Takenari Yamashita ; Hideyama T; Kwak S
    Brain Res; 2014 Mar; 1550():36-46. PubMed ID: 24440630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology.
    Yamashita T; Hideyama T; Hachiga K; Teramoto S; Takano J; Iwata N; Saido TC; Kwak S
    Nat Commun; 2012; 3():1307. PubMed ID: 23250437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
    Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
    EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
    Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
    Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
    Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
    J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.